Autoimmune-mediated congenital heart block

被引:42
|
作者
Wainwright, Benjamin [1 ]
Bhan, Rohit [1 ]
Trad, Catherine [1 ]
Cohen, Rebecca [1 ]
Saxena, Amit [1 ]
Buyon, Jill [1 ]
Izmirly, Peter [1 ]
机构
[1] NYU, Sch Med, New York, NY USA
关键词
Congenital heart block; Anti-SSA/Ro autoantibodies; Neonatal lupus; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIAC NEONATAL LUPUS; ANTI-RO/SSA ANTIBODIES; AMINO-ACID; 200-239; CUTANEOUS MANIFESTATIONS; MATERNAL AUTOANTIBODIES; FLUORINATED STEROIDS; SSB/LA ANTIBODIES; RECURRENCE RATES; INFANTS BORN;
D O I
10.1016/j.bpobgyn.2019.09.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Autoimmune-mediated congenital heart block (CHB) is a severe manifestation of neonatal lupus in which conduction tissues of the fetal heart are damaged. This occurs due to passive transference of maternal anti-SSA/Ro and anti-SSB/La autoantibodies and subsequent inflammation and fibrosis of the atrioventricular (AV) node. Notably, the disease manifests after the fetal heart has structurally developed, ruling out other anatomical abnormalities that could otherwise contribute to the block of conduction. Complete AV block is irreversible and the most common manifestation of CHB, although other cardiac complications such as endocardial fibroelastosis (EFE), dilated cardiomyopathy, and valvular insufficiency have been observed. In this review, we detail the classification, prevalence, pathogenesis, and clinical management recommendations for autoimmune CHB. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 50 条
  • [1] Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block
    Suryawanshi, Hemant
    Clancy, Robert
    Morozov, Pavel
    Halushka, Marc K.
    Buyon, Jill P.
    Tuschl, Thomas
    CARDIOVASCULAR RESEARCH, 2020, 116 (08) : 1446 - 1457
  • [2] Treatment options for preventing autoimmune-mediated congenital heart block: a systematic review
    Agarwal, Abhishek
    Skoutelis, Nikolaos
    Zhou, Yufeng
    Kawanami, Reina
    Charras, Amandine
    Occhigrossi, Felice
    Agarwal, Umber
    Khan, Sophia
    Donegan, Sarah
    Hawcutt, Daniel
    ARCHIVES OF DISEASE IN CHILDHOOD, 2025,
  • [3] European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block
    Kyriakidis, Nikolaos C.
    Kockum, Ingrid
    Julkunen, Heikki
    Hoxha, Ariela
    Salomonsson, Stina
    Meneghel, Lauro
    Ebbing, Cathrine
    Dilthey, Alexander
    Eronen, Marianne
    De Carolis, Sara
    Kiserud, Torvid
    Ruffatti, Amelia
    Kere, Juha
    Meisgen, Sabrina
    Wahren-Herlenius, Marie
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (09) : 1381 - +
  • [4] Autoimmune-mediated congenital heart block: long-term cardiovascular outcome in a tertiary centre experience
    Zanetti, Claudia
    Cerutti, Alessia
    Leoni, Loira
    Biffanti, Roberta
    Reffo, Elena
    Castaldi, Biagio
    Sirico, Domenico
    Padalino, Massimo
    Vladimiro, Vida
    Di Salvo, Giovanni
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N50 - N51
  • [5] Autoimmune-mediated encephalitis
    Demaerel, Philippe
    Van Dessel, Wim
    Van Paesschen, Wim
    Vandenberghe, Rik
    Van Laere, Koen
    Linn, Jennifer
    NEURORADIOLOGY, 2011, 53 (11) : 837 - 851
  • [6] Autoimmune-mediated vasculopathy
    Chen, WR
    Thoburn, CJ
    Miura, Y
    Sommer, M
    Hruban, R
    Qian, ZP
    Baldwin, W
    Hess, AD
    CLINICAL IMMUNOLOGY, 2001, 100 (01) : 57 - 70
  • [7] Autoimmune-mediated atherothrombosis
    Matsuura, E.
    Lopez, L. R.
    LUPUS, 2008, 17 (10) : 878 - 887
  • [8] Autoimmune-mediated astrocytopathy
    Makoto Kinoshita
    Tatsusada Okuno
    Inflammation and Regeneration, 43
  • [9] Autoimmune-mediated astrocytopathy
    Kinoshita, Makoto
    Okuno, Tatsusada
    INFLAMMATION AND REGENERATION, 2023, 43 (01)
  • [10] Autoimmune-mediated hemotoxicities
    Vultaggio, Alessandra
    Matucci, Andrea
    Nencini, Francesca
    Bormioli, Susanna
    Maggi, Enrico
    CURRENT OPINION IN TOXICOLOGY, 2020, 19 : 63 - 67